108 related articles for article (PubMed ID: 23361938)
21. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
22. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
Zhao Z; Sui Y; Gao W; Cai B; Fan D
J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
[TBL] [Abstract][Full Text] [Related]
23. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
[TBL] [Abstract][Full Text] [Related]
24. Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis.
Sone J; Niwa J; Kawai K; Ishigaki S; Yamada S; Adachi H; Katsuno M; Tanaka F; Doyu M; Sobue G
J Neurosci Res; 2010 Jan; 88(1):123-35. PubMed ID: 19610091
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.
Knippenberg S; Sipos J; Thau-Habermann N; Körner S; Rath KJ; Dengler R; Petri S
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1052-61. PubMed ID: 24128678
[TBL] [Abstract][Full Text] [Related]
26. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
28. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
29. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
[TBL] [Abstract][Full Text] [Related]
30. ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation.
Arrat H; Lukas TJ; Siddique T
PLoS One; 2015; 10(5):e0125638. PubMed ID: 25955410
[TBL] [Abstract][Full Text] [Related]
31. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
[TBL] [Abstract][Full Text] [Related]
32. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
33. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.
Shimojo Y; Kosaka K; Noda Y; Shimizu T; Shirasawa T
J Neurosci Res; 2010 Mar; 88(4):896-904. PubMed ID: 19798750
[TBL] [Abstract][Full Text] [Related]
34. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
35. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
36. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
37. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
[TBL] [Abstract][Full Text] [Related]
38. Assessing the role of immuno-proteasomes in a mouse model of familial ALS.
Puttaparthi K; Van Kaer L; Elliott JL
Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis.
Cimini S; Rizzardini M; Biella G; Cantoni L
J Neurochem; 2014 May; 129(3):413-25. PubMed ID: 24359187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]